Charles Stacey

Charles Stacey Email and Phone Number

Biotech CEO | Life Science Investor | Health Futurist @ Cerecin
Charles Stacey's Location
Singapore, Singapore
Charles Stacey's Contact Details
About Charles Stacey

Charles has over 20 years of experience in healthcare working as a provider, entrepreneur and investor. He now leverages this breadth of experience in leading Cerecin in the fight against neurological diseases and brain health.Prior to joining Cerecin, Charles was with Inventages, a global healthcare venture capital and private equity group with $1.5 billion under management. Inventages was one of the world's first and leading funds with a focus on nutrition and wellness. Charles managed all stages of the investment life cycle: deal sourcing, due diligence and supporting portfolio companies. Charles has a specialist interest and particular experience in investments in the brain health, digital health and emerging markets (particularly Asia). Earlier in his career, Charles co-founded a medical device company to develop a product that he invented through the course of his clinical work as a trauma surgeon. During this time he also consulted to other healthcare start ups and Safeguard Scientific, a US-based venture capital firm. Before this Charles worked as an orthopedic and reconstructive surgeon in London specializing in lower limb and hand surgery. Charles received his medical degree from King’s College London and trained in general medical and surgical specialties in London/Surrey, UK. He also has a BSc in Neuroscience from University College London, an MSc in Surgical Technology from Imperial College and an MBA from the London Business School and the Wharton School.

Charles Stacey's Current Company Details
Cerecin

Cerecin

View
Biotech CEO | Life Science Investor | Health Futurist
Charles Stacey Work Experience Details
  • Cerecin
    President And Ceo
    Cerecin Mar 2018 - Present
    Central Business District, Sg
    Cerecin, Inc., is a privately held biotech company that develops therapies to treat central nervous system disorders. The lead candidate, Tricaprilin is currently in late stage clinical trials for mild-moderate Alzheimer's disease. [Charles held the role of interim-CEO from January to September 2014]
  • Cerecin
    President And Ceo (Accera Pharmaceuticals)
    Cerecin Feb 2015 - Mar 2018
    Central Business District, Sg
  • Co11Ab Novena
    Industry Advisory Panel (Iap)
    Co11Ab Novena Jun 2024 - Present
    co11ab Novena is a BioMedTech incubator – a tripartite alliance between Nanyang Technological University NTU, Singapore, Agency for Science, Technology, and Research (A*STAR), and National Healthcare Group (NHG).
  • One Six 8 Ventures
    Venture Partner
    One Six 8 Ventures Mar 2024 - Present
    Calgary, Alberta, Ca
    One Six 8 Ventures is a venture capital firm based in Western Canada. Our seasoned team of industry executives and investors provide support to early-stage health and life sciences companies within the Canadian ecosystem. Our mission is to nurture innovation and accelerate the growth of promising startups.
  • Accreditation Council For Medical Affairs (Acma)
    Member Of Board Of Governors
    Accreditation Council For Medical Affairs (Acma) Sep 2018 - Present
    Greater New York Area, New Jersey, Us
    Accreditation Council for Medical Affairs is a self-governing, independent organization which promotes standards of excellence around both core technical competencies and ethical practices for pharmaceutical industry professionals in medical affairs.
  • Nanyang Technological University Singapore
    Guest Lecturer
    Nanyang Technological University Singapore Oct 2020 - Present
    Singapore, Singapore, Sg
    Guest lecturer @ Lee Kong Chian School of Medicine, NTU- Bio-Entrepreneurship Course - LKCMed Year 2 Innovations in Medicine Lecture
  • Ypo, Singapore
    Executive Committee Member
    Ypo, Singapore Nov 2020 - Present
    Executive Committee Member, YPO Singapore Integrated
  • General Medical Council
    Member
    General Medical Council Sep 2003 - Present
    London, Gb
  • Emteq Labs
    Investor
    Emteq Labs Nov 2023 - Present
    Brighton, Gb
  • Alzheimer'S Association Business Consortium (Aabc)
    Founder Chairman
    Alzheimer'S Association Business Consortium (Aabc) 2015 - Jan 2018
    Founded in 2015, the mission of the AABC is to support the advancement of Alzheimer’s disease research and innovation in small companies.
  • Gc-Rise Pharmaceuticals
    Board Of Directors, Member
    Gc-Rise Pharmaceuticals Feb 2011 - Jun 2015
    A leading Chinese pharmaceutical company specialising in women's and children's health. GC-Rise has a sales force of over 500 sales reps enabling access to the majority of the Chinese market. GC-Rise has won the Deloitte's 50 Top-performing Company Award for 3 consecutive years (the only pharmaceutical company to receive this award in 2013).
  • Inventages Venture Capital
    Senior Investment Manager
    Inventages Venture Capital 2010 - Feb 2015
    Ch
    One of the largest healthcare venture capital and private equity groups with $1.5 billion under management. Inventages has a particular focus on therapeutics for chronic chronic disease, wellness/longevity and preventative health. Charles has responsibility for five portfolio companies and has led/supported six equity transactions (inc. follow on investments) totaling almost $200M. Charles’ area of focus was neuroscience and digital health.
  • Cognoptix Inc
    Board Of Directors, Observer
    Cognoptix Inc Jun 2011 - Nov 2014
    Cognoptix, a company headquartered in Acton, Mass., is focused on developing and commercializing an in-office, drug/device diagnostic system as an aid in the early detection of Alzheimer’s Disease. The feasibility study showed unprecedented accuracy, with a specificity of 95% and sensitivity of 85% at differentiating Alzheimer's disease patients from healthy controls . Sapphire II provides physicians with a quick, easy and cost-effective method to objectively detect Beta-Amyloid in the central nervous system, the hallmark of Alzheimer's disease.
  • Myoton
    Chief Medical Officer & Business Development
    Myoton Mar 2009 - Oct 2010
    Chief Medical Officer to Myoton, a European medical device company with novel CNS diagnostic device. Leading of clinical strategy and development of clinical collaborations and trials at top UK clinical sites including the Institute of Neurology, Queen Square.
  • Flexycast Ltd
    Co-Founder, Co-President And Medical Lead
    Flexycast Ltd 2008 - Oct 2010
    Founded a company to develop and commercialize a novel orthopaedic splinting technology that was invented through the course of clinical practice. Raised equity funding and built a multidisciplinary team, consisting of design, engineering, IP and regulatory expertise.
  • Nhs
    Trauma And Reconstructive Surgeon
    Nhs 2002 - Aug 2009
    Gb
    Charles worked as an orthopedic and reconstructive surgeon at leading teaching hospitals in London and South East England.

Charles Stacey Skills

Healthcare Clinical Research Venture Capital Pharmaceutical Industry Private Equity Orthopedic Lifesciences Hardware Diagnostics Biotechnology Hospitals Healthcare Information Technology Medical Devices Commercialization Neurology Diagnostics Clinical China Pharmaceuticals Healthcare It Orthopedics Life Science Venture Capital Healthcare Venture Capital South East Asia Emerging Markets

Charles Stacey Education Details

  • London Business School
    London Business School
    Exchange Programme With Wharton Business School
  • The Wharton School
    The Wharton School
    Exchange Program From Lbs
  • Royal College Of Surgeons Of England
    Royal College Of Surgeons Of England
    Member Of Royal College Of The Surgeons
  • Imperial College London
    Imperial College London
    Prof A. Darzi
  • King'S College London
    King'S College London
    Medicine
  • Ucl
    Ucl
    Neuroscience
  • Tonbridge School, Kent
    Tonbridge School, Kent

Frequently Asked Questions about Charles Stacey

What company does Charles Stacey work for?

Charles Stacey works for Cerecin

What is Charles Stacey's role at the current company?

Charles Stacey's current role is Biotech CEO | Life Science Investor | Health Futurist.

What is Charles Stacey's email address?

Charles Stacey's email address is nc****@****ail.com

What schools did Charles Stacey attend?

Charles Stacey attended London Business School, The Wharton School, Royal College Of Surgeons Of England, Imperial College London, King's College London, Ucl, Tonbridge School, Kent.

What skills is Charles Stacey known for?

Charles Stacey has skills like Healthcare, Clinical Research, Venture Capital, Pharmaceutical Industry, Private Equity, Orthopedic, Lifesciences, Hardware Diagnostics, Biotechnology, Hospitals, Healthcare Information Technology, Medical Devices.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.